title: A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis.
abstract: Along with the most common mutation, JAK2V617F, several other acquired JAK2 mutations have now been shown to contribute to the pathogenesis of myeloproliferative neoplasms (MPNs). However, here we describe for the first time a germline mutation that leads to familial thrombocytosis that involves a residue other than Val617. The novel mutation JAK2R564Q, identified in a family with autosomal dominant essential thrombocythemia, increased cell growth resulting from suppression of apoptosis in Ba/F3-MPL cells. Although JAK2R564Q and JAK2V617F have similar levels of increased kinase activity, the growth-promoting effects of JAK2R564Q are much milder than those of JAK2V617F because of at least 2 counterregulatory mechanisms. Whereas JAK2V617F can escape regulation by the suppressor of cytokine signaling 3 and p27/Kip1, JAK2R564Q-expressing cells cannot. Moreover, JAK2R564Q-expressing cells are much more sensitive to the JAK inhibitor, ruxolitinib, than JAK2V617F-expressers, suggesting that lower doses of this drug may be effective in treating patients with MPNs associated with alternative JAK2 mutations, allowing many undesirable adverse effects to be avoided. This work provides a greater understanding of the cellular effects of a non-JAK2V617F, MPN-associated JAK2 mutation; provides insights into new treatment strategies for such patients; and describes the first case of familial thrombosis caused by a JAK2 residue other than Val617.
authors.affiliation: Department of Medicine.
authors.forename: S Leah
authors.initials: SL
authors.lastname: Etheridge
authors.forename: Megan E
authors.initials: ME
authors.lastname: Cosgrove
authors.forename: Veena
authors.initials: V
authors.lastname: Sangkhae
authors.forename: Lana M
authors.initials: LM
authors.lastname: Corbo
authors.forename: Michelle E
authors.initials: ME
authors.lastname: Roh
authors.forename: Markus A
authors.initials: MA
authors.lastname: Seeliger
authors.forename: Edward L
authors.initials: EL
authors.lastname: Chan
authors.forename: Ian S
authors.initials: IS
authors.lastname: Hitchcock
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D001120:Arginine / Q000235:genetics; D001483:Base Sequence; D002648:Child; D005260:Female; D018095:Germ-Line Mutation; D018698:Glutamic Acid / Q000235:genetics; D006801:Humans; D053614:Janus Kinase 2 / Q000737:chemistry / Q000235:genetics*; D008297:Male; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010375:Pedigree; D013920:Thrombocythemia, Essential / Q000235:genetics*
chemical_list: D018698:Glutamic Acid; D001120:Arginine; C507924:JAK2 protein, human; D053614:Janus Kinase 2